Table 1.
Group | MMF, oral administration |
Sirolimus, oral administration |
Daclizumab, intravenous administration |
||
---|---|---|---|---|---|
Dose/schedule | Duration | Dose/schedule | Duration | Dose/schedule | |
1 | NA | NA | NA | NA | NA |
2 | 25 mg/kg twice daily | From d −7 to d 70 | 2 mg/kg once daily | From d +3 to d 70 | 2 mg/kg at d −1; 1 mg/kg at d 15 |
3 | 25 mg/kg twice daily | From d −7 to d 70 | 4 mg/kg once daily; 2 mg/kg once daily | From d 1 to d 7; from d 8 to d 70 | NA; NA |
For each group (n = 3), the AAV2-hF.IX vector at a dose of 8 × 1012 vg/kg was used.
NA indicates not applicable.